MALAT1 and lung carcinoma: Subcutaneous injection of ASOs targeting the lncRNA MALAT1 is sufficient to reduce the formation of breast and lung cancer metastasis in MMTV-PyMT mouse mammary carcinoma and lung cancer xenograft models, respectively [174,175].